TB
#UNGA73: Making the UN Relevant to all People
This post was written by Victoria Rodriguez, Advocacy Associate at Global Health Council. This year marked the 73rd session of the UN General Assembly (UNGA). UNGA73 focused on making the UN relevant to all people through shared responsibilities for peaceful and equitable global leadership. In conjunction, the third high-level meeting (HLM) on noncommunicable diseases (NCDs)…
Read MoreInvesting in TB Research: World Leaders Urged to Commit to End TB
This blog post was written by the Communications Team at the Global Alliance for TB Drug Development (TB Alliance). TB Alliance is dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them. They are a 2018 Global Health Council Member. A Lingering Epidemic Tuberculosis…
Read MoreThe Local Path to Global Health Security
This article was originally published in Global Health NOW. The article is around a WHA side-event organized by Global Health Council & partners. Global Health NOW has gathered thousands of subscribers worldwide who rely on it as a source for their global health news. The mobile-ready website globalhealthnow.org came online in March 2015, delivering more exclusive…
Read MoreNew Hope for Children with TB
This blog was written by the communications team at TB Alliance as part of Global Health Council’s Member Spotlight Series. Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are available to those who need them. TB Alliance is…
Read MoreThe Fight against TB: The Forgotten Battle
This post was written by Nicole Cho, Global Health Council (GHC) Intern. Tuberculosis (TB), the bacterial infection that mainly infects the lungs and is believed to have caused more deaths than famines and wars combined, is often seen as an ailment of the past. This conception seems true because sanitariums for consumption are no longer…
Read MoreFighting Big Diseases with Little Computers
This guest post was written by Jordan Coriza , Media Relations Manager and Content Editor, Management Sciences for Health (MSH). It was originally published on MSH’s website. HOW HEALTH WORKERS USE TECHNOLOGY TO COMBAT ILLNESS Treatments for diseases like tuberculosis (TB) and HIV are lengthy and complex. Medications need to be taken regularly and for…
Read MoreRESULTS' Legacy of TB Advocacy
Tuberculosis (TB) is one of the most pressing global health challenges of our time. Despite being preventable and curable, TB kills approximately 250,000 people a year. What’s more, curing TB requires a lengthy treatment period, which is often interrupted by poor access and adherence to therapy. Moreover, multi-drug resistant strains of TB are emerging at alarming rates in several regions across…
Read MorePQM Increases the Supply of, and Affordability of, Life-Saving Anti-TB Medication
This guest post was provided by GHC member United States Pharmacopeial Convention (USP). The United States Pharmacopeial Convention (USP) promotes and supports end-to-end quality assurance across health systems in partnership with regulatory authorities, policymakers, donors, and other key stakeholders. Through multiple programs, USP provides technical assistance, workforce development, and sets standards to improve access to…
Read MoreA year in review: The top stories in global health innovation that shaped 2016
This guest post was written by Kat Kelley, Senior Program Assistant at Global Health Technologies Coalition (GHTC), and originally appeared on GHTC’s website. 2016 was a year that ushered in significant shifts in the global health landscape. We witnessed the waning of the Ebola epidemic and the waxing of the Zika outbreak; important leadership changes…
Read MoreKenya Leads World’s First Nation-wide Introduction of New Child-Friendly TB Medicines
This post was provided by GHC member, TB Alliance New drugs designed to treat pediatric TB are expected to improve child survival On October 1, 2016, Kenya launched simpler and more affordable fixed dose combinations for drugs to treat tuberculosis (TB) in children. This was the first national roll out of these improved medicines. Working…
Read More